Prakhar Agrawal
Stock Analyst at Cantor Fitzgerald
(1.86)
# 3,033
Out of 4,734 analysts
47
Total ratings
28.57%
Success rate
-3.44%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Prakhar Agrawal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORIC ORIC Pharmaceuticals | Reiterates: Overweight | n/a | $9.58 | - | 6 | Jan 14, 2025 | |
| ATYR aTyr Pharma | Initiates: Overweight | n/a | $3.59 | - | 1 | Jan 6, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Overweight | $10 | $5.01 | +99.58% | 1 | Dec 17, 2024 | |
| KROS Keros Therapeutics | Reiterates: Overweight | n/a | $11.48 | - | 2 | Nov 22, 2024 | |
| MDGL Madrigal Pharmaceuticals | Reiterates: Neutral | n/a | $302.48 | - | 4 | Nov 20, 2024 | |
| GPCR Structure Therapeutics | Reiterates: Overweight | $65 | $28.27 | +129.97% | 12 | Sep 23, 2024 | |
| MLTX MoonLake Immunotherapeutics | Reiterates: Overweight | n/a | $46.54 | - | 10 | Sep 23, 2024 | |
| AKRO Akero Therapeutics | Reiterates: Overweight | n/a | $25.53 | - | 5 | Jun 20, 2024 | |
| RAPT RAPT Therapeutics | Downgrades: Neutral | n/a | $1.23 | - | 2 | Feb 20, 2024 | |
| TGTX TG Therapeutics | Reiterates: Overweight | $24 | $30.01 | -20.03% | 2 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $450 | $1.83 | +24,483.45% | 1 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $0.62 | +2,158.43% | 1 | Mar 3, 2021 |
ORIC Pharmaceuticals
Jan 14, 2025
Reiterates: Overweight
Price Target: n/a
Current: $9.58
Upside: -
aTyr Pharma
Jan 6, 2025
Initiates: Overweight
Price Target: n/a
Current: $3.59
Upside: -
TriSalus Life Sciences
Dec 17, 2024
Initiates: Overweight
Price Target: $10
Current: $5.01
Upside: +99.58%
Keros Therapeutics
Nov 22, 2024
Reiterates: Overweight
Price Target: n/a
Current: $11.48
Upside: -
Madrigal Pharmaceuticals
Nov 20, 2024
Reiterates: Neutral
Price Target: n/a
Current: $302.48
Upside: -
Structure Therapeutics
Sep 23, 2024
Reiterates: Overweight
Price Target: $65
Current: $28.27
Upside: +129.97%
MoonLake Immunotherapeutics
Sep 23, 2024
Reiterates: Overweight
Price Target: n/a
Current: $46.54
Upside: -
Akero Therapeutics
Jun 20, 2024
Reiterates: Overweight
Price Target: n/a
Current: $25.53
Upside: -
RAPT Therapeutics
Feb 20, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.23
Upside: -
TG Therapeutics
Apr 17, 2023
Reiterates: Overweight
Price Target: $24
Current: $30.01
Upside: -20.03%
Jul 15, 2022
Assumes: Overweight
Price Target: $450
Current: $1.83
Upside: +24,483.45%
Mar 3, 2021
Initiates: Buy
Price Target: $14
Current: $0.62
Upside: +2,158.43%